Navigation Links
NuVasive to Present at Barclays Capital Global Healthcare Conference
Date:3/3/2009
SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer and Kevin O'Boyle, Executive Vice President & Chief Financial Officer, are scheduled to present at the Barclays Capital Global Healthcare Conference at Loews Miami Beach Hotel in Miami Beach, Florida on Tuesday, March 10, 2009, at 8:30 a.m. ET.
A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, www.nuvasive.com, for 30 days.
About NuVasive
NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(R), as well as a growing offering of biologics, cervical and motion preservation products.
The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines four categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; biologics; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption durin
'/>"/>
| SOURCE NuVasive, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results
2. NuVasive Announces Web Cast and Conference Call of Fourth Quarter 2008 Results
3. NuVasive to Present at Canaccord Adams Musculoskeletal Conference
4. NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference
5. NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results
6. NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference
7. NuVasive to Present at 20th Annual Piper Jaffray Health Care Conference
8. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
9. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. NuVasive Reports First Quarter 2008 Financial Results
Post Your Comments:
(Date:5/24/2013)... News) -- Drugs commonly used to treat glaucoma may ... interfere with vision, according to a new study. ... used to reduce eye pressure, have already been shown ... color, the researchers said, suggesting that the new findings ... Doctors should be conservative when prescribing these drugs, the ...
(Date:5/24/2013)... Let’s face it: very few are luckily ... the majority of people to be uncomfortable with the color ... coffee addiction or simply genetics, yellowish or stained teeth suppresses ... , Herald Square Dental is proud to announce ... Venus White Max. , Teeth become discolored for a ...
(Date:5/24/2013)... Chino, CA (PRWEB) May 24, 2013 Area ... huge selection of new hot tubs to choose from at ... Super Sale . The sales event takes place at ... May 26, 2013. , Jacuzzi, the industry's leading hot ... sale traveling across the country. The event will feature popular ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... lawsuit involving Intuitive Surgical Inc.’s da Vinci Surgical ... to court records, a Washington State Court jury ruled ... negligence in training a surgeon who performed a da ... later. The patient’s family had alleged in their ...
(Date:5/24/2013)... development of infantile myofibromatosis (IM)a disorder characterized by multiple ... new therapeutic targets, according to researchers from the Icahn ... in the American Journal of Human Genetics , ... disease, for which the only current treatment option is ... an inheritied disorder that develops in infancy or even ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2[0] Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds[0] Herald Square Dental Introduces New In-office Whitening System: Venus White Max[0] Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event[0] Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications[0] Researchers identify first drug targets in childhood genetic tumor disorder
... ... , ... 2009 -- Exercise is a critical piece of a healthy lifestyle, however, those who suffer ... January/February 2010 issue of Sports Health: A Multidisciplinary Approach. Authors confirm that exercise can aid ...
... At only 5-years ... Television and News shows including The Oprah Winfrey Show and Good morning America, Julian Pavone ... double kick. , ... 29, 2009 -- As a traveling Rock Star at such a young tender age, Julian’s ...
... ... Care Act , ... over 2000 pages contained within HR 3200, the House Bill that the recently passed Senate ... Americans thanks to a cooperative effort between Hearthebill.org and iScroll , developers of the ...
... , MOUNT PROSPECT, Ill., Dec. 28 On ... (NABP(R)) reached a bitter-sweet milestone in its ongoing review of ... 5,000 Internet drug outlets as Not Recommended. These sites -- ... been found to be out of compliance with pharmacy laws ...
... Germ linked to tooth decay evolved from a beneficial organism, ... research provides insights into the genetic makeup of a germ ... a great job of colonizing the mouth. , The ... related germs are best known for sitting in the gut ...
... , , , BIRMINGHAM, Ala., Dec. ... M.D., has some simple resolutions and fun advice for ... a board-certified clinical lipidologist (NLA), certified hypertension specialist (ASH), ... in Sandy, Utah, and Chief Medical Officer at Atherotech, ...
Cached Medicine News:Health News:Exercise May Reduce the Complications of Diabetes, According to Sports Health Journal Study 2Health News:Exercise May Reduce the Complications of Diabetes, According to Sports Health Journal Study 3Health News:Life Ionizers Drums to a New Beat with Julian Pavone, the Worlds Youngest Drummer and Inventor 2Health News:House Health Care Bill Becomes Up To 38% More Understandable 2Health News:5,000 Web Sites Selling Prescription Drugs Outside of Pharmacy Laws and Practice Standards 2Health News:5,000 Web Sites Selling Prescription Drugs Outside of Pharmacy Laws and Practice Standards 3Health News:Heart-Healthy ABC's for 2010 2Exercise May Reduce the Complications of Diabetes, According to Sports Health Journal StudyLife Ionizers Drums to a New Beat with Julian Pavone, the Worlds Youngest Drummer and InventorHouse Health Care Bill Becomes Up To 38% More Understandable 5,000 Web Sites Selling Prescription Drugs Outside of Pharmacy Laws and Practice StandardsCavity-Causing Bacteria May Have Originated in GutHeart-Healthy ABC's for 2010
(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering. In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering. A portion of the ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4... to March 24 article in the ... Medicine ALEXANDRIA, Va. and JACKSONVILLE, Fla., March 24 ... New England Journal of Medicine suggests that intensive ... hyperglycemia (high blood glucose) does not improve outcomes and ...
... of concept for company,s first-in-class SERM designed to ... hormone therapy--CAMBRIDGE, Mass., March 24 Radius Health ... been dosed in the company,s proof-of-concept Phase 2a ... modulator (SERM) undergoing clinical evaluation for treatment of ...
Cached Medicine Technology:Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 2Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 3Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 4Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 2Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 3... two staggered eyes. It is made ... adapter is enclosed. They are color ... right. They are for single use, ... length is 65cm and they are ...
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... RiteCut Right Angle Cutting Electrode is ... with a general purpose monopolar electrosurgical ... with any ACMI rigid, semi-rigid, or ... has a working channel larger than ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |